News

Ondine Biomedical names Alan Thomas as interim chief financial officer
(Alliance News) - Ondine Biomedical Inc on Friday appointed Alan Thomas as its non-board interim chief financial officer, effective immediately. The Vancouver, Canada-based life sciences company said ...
London Security warns of potential downturn as profit slips in 2024
(Alliance News) - London Security PLC on Friday reported lower profit in 2024 and said the markets it operates in could be entering a period of low growth. The West Yorkshire, England-based ...
Tariffs not causing "dramatic" shift in UK economy, BoE's Pill says
(Alliance News) - Tariffs and trade uncertainty are not causing a "dramatic" shift in the UK economy, the Bank of England's chief economist has said, as he cautioned over "misleading" views on the ...
Newbury Racecourse shares jump after profit and revenue increase
Newbury Racecourse shares rose 11% to 565.00 pence on Friday morning on London's Aquis Exchange. The Newbury, England-based racing, entertainment and events business reported a pretax profit of GBP1.1 ...
LONDON BRIEFING: LondonMetric buys Urban Logistics for GBP699 million
Morgan Stanley raises Haleon to 'overweight' - price target 425 pence ...
Centrica flags soft trading at its British Gas and Energy divisions
This is primarily due to more "challenging" market conditions in the gas & power trading segment, Centrica noted. Centrica said the adjusted operating profit range for financial 2025 at British Gas ...
Airtel Africa revenue hit by currency devaluation; eyes 2026 unit IPO
Airtel's revenue for the year was USD4.96 billion, down 0.5% from USD4.98 billion. This was due to currency devaluation impacting reported revenue. At constant currency, it expanded 21%. "Reported ...
London close: Stocks mixed on BoE rate cut, US-UK trade deal
(Sharecast News) - London equities ended Thursday in mixed territory, as investors digested US president Donald Trump declaring a US-UK trade deal, while the Bank of England delivered an expected ...
GSK hails phase 3 results on linerixibat in treating relentless itch
The London-based pharmaceutical company said in a phase 3 trial, primary and key secondary endpoints were met, which demonstrated a "rapid, significant and sustained improvement" in cholestatic ...
IMI confirms full-year growth guidance despite first-quarter decline
Looking ahead, the firm expects to post mid-single digit organic revenue growth in 2025. IMI also reconfirmed guidance for full-year adjusted earnings per share between 129 pence and 136p, which would ...
UPDATE: Trump calls US-UK agreement "full and comprehensive"
(Alliance News) - US President Donald Trump on Thursday called a forthcoming agreement with Britain "full and comprehensive", after US media reported that the two countries were expected to sign a ...
LONDON BROKER RATINGS: Deutsche Bank cuts BT Group and Deliveroo
(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and on Tuesday: Morgan Stanley cuts GSK price target to 1,355 (1,450) pence - 'underweight' ...